Asset sale, adviser appointment, notice of results

Hipgnosis Songs Fund Limited
11 December 2023
 

LEI: 213800XJIPNDVKXMOC11

11 December 2023

Hipgnosis Songs Fund Limited ("Hipgnosis" or the "Company")

Sale of non-core assets, appointment of advisers and notice of interim results

Sale of None-core Assets

Further to the announcement of 14 September 2023, the Board of Hipgnosis Songs Fund Limited has completed the sale of c.20,000 songs (the "Songs") for a gross consideration of $23.1 million, representing approximately 1% by value of the Company's investment portfolio.  

These non-core songs, which are a subset of those identified as the Second Disposal as set out in September, were bundled with the iconic Songs acquired by the Company in 2020 as part of Kobalt Fund One.  They require time intensive, ongoing accounting and reporting obligations and do not all have perpetual ownership rights.  Their eventual sale was part of the Company's acquisition strategy. 

The gross consideration reflects a 14.2% discount to the valuation of the Songs prepared by the Company's Portfolio Independent Valuer as at 30 September 2023 and represents a 9.6x Net Publisher Share multiple.  Net proceeds are expected to equal approximately $22.6 million.

The net proceeds of the sale will be used to pay down RCF drawings, providing the Company with greater headroom under its future covenant compliance reporting.

Appointment of Advisers

The Company is pleased to announce the appointment of Singer Capital Markets as sole corporate broker and financial adviser and Shot Tower Capital, LLC as lead adviser to conduct due diligence on the Company's assets as part of its strategic review.   

 

Notice of Interim Results

The Company will announce its financial results for the six months to 30 September 2023 on Tuesday 19 December 2023.

There will be a briefing for analysts and investors at 08:30 on the day of announcement.

To register to participate, please contact ir@hipgnosissongs.com.

A recording of the call will subsequently be placed on the Company's website www.hipgnosissongs.com/song-investors/

 

For further information please contact:
Hipgnosis Songs Fund

Robert Naylor / Sylvia Coleman

Via Singer Capital Markets

 

Hipgnosis Song Management

Merck Mercuriadis

Ben Katovsky

Giles Croot (Media)

 


 

 

+44 (0) 20 7496 3000

 

 

 

+44 (0) 20 4542 1530

+44 (0) 20 4542 1511

 

Singer Capital Markets - Corporate Broker

James Moat / Alaina Wong / Angus Campbell (Corporate Finance)

Alan Geeves / James Waterlow / Sam Greatrex (Sales) 


 

+44 (0) 20 7496 3000

Headland Consultancy - Financial PR

Susanna Voyle / Charlie Twigg

 


+44 (0) 20 3805 4822

 





 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
Investor Meets Company
UK 100